Generic Semaglutide was authorized by Health Canada in 2026
This regulatory development is highly relevant to industry as it signals a shift toward more integrated and technology-driven weight management approaches and chronic disease prevention strategies In this space, Kelker Pharma recently introduced Nutrilinq Genesis, touted as the first science-backed nutritional support system for GLP-1 therapy patients
For women with type 2 diabetes or prediabetes, weight loss often significantly improves glycemic control
If you've been googling "retatrutide FDA approval 2025 2026," you're not alone
The advantages include not just improved cardiovascular function and better blood sugar management but also reduced joint pain, enhanced mobility, and improved self-esteem
But also, this is a drug that as long as I take it, it's going to reduce my appetite and I'm going to lose weight